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LIST OF ABBREVIATIONS 
 
BCC Bovine Chromaffin Cell 
BK Big conductance K+ channels 
DMEM Dulbecco’s Modified Eagle’s Medium 
ER Endoplasmic reticulum 
Fura-2AM Fura-2 acetoxymethyl ester  
S1P Sphingosine-1-phosphate  
SERCA Sarco-endoplasmic Reticulum Calcium ATPase 
TG Thapsigargin 
TTX Tetrodotoxin 
VACC Voltage-activated Calcium Channels 
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ABSTRACT 
In searching for druggable synthetic lipids as potential modulators of synaptic transmission and 
plasticity, we synthesized sulfoglycolipid IG20 that stimulates neuritic outgrowth. Here we have 
explored its effects on ion channels and exocytosis in bovine chromaffin cells (BCCs). IG20 
augmented the rate of basal catecholamine release. Such effect did not depend on Ca2+ mobilization 
from intracellular stores; rather, IG20-elicited secretion entirely dependent on Ca2+ entry through L-
subtype voltage-activated Ca2+ channels. Those channels were recruited by cell depolarization 
mediated by IG20 likely through its ability to enhance the recruitment of Na+ channels at more 
hyperpolarizing potentials. Confocal imaging with fluorescent derivative IG20-NBD revealed its rapid 
incorporation and confinement into the plasmalemma, supporting the idea that IG20 effects are exerted 
through a plasmalemmal-delimited mechanism. Thus, synthetic IG20 seems to mimic several 
physiological effects of endogenous lipids such as regulation of ion channels, Ca2+ signaling, and 
exocytosis. Therefore, sulfoglycolipid IG20 may become a pharmacological tool to investigate the role 
of the lipid environment on neuronal excitability, ion channels, neurotransmitter release, synaptic 
efficacy, and neuronal plasticity. It may also inspire the synthesis of druggable sulfoglycolipids aimed 
at increasing synaptic plasticity and efficacy in neurodegenerative diseases and traumatic brain – 
spinal cord injury. 
 
 
 
Keywords: Compound IG20; exocytosis; sodium channel; calcium channel; sulfoglycolipid; 
chromaffin cell 
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INTRODUCTION 
It is known that cholesterol, sphingolipids, and phospholipids with saturated acyl tails coalesce to form 
tightly packed aggregates known as lipid rafts (Simons & Ikonen 1997). The only morphologically 
identifiable raft-like domain is the caveola. Association with the protein caveolin causes the 
cholesterol- and sphingolipid-enriched regions of the membrane to bulge into the cell forming flask-
shaped pits (Razani et al. 2002). Interaction of ion channel proteins with caveolin appears to regulate 
channel function either directly by altering the channel kinetics or indirectly by affecting trafficking 
and surface expression (Jiao et al. 2008, Lee et al. 2009). Raft-enriched lipids such as cholesterol and 
sphingolipids can also exert effects on channel activity either through direct protein-lipid interactions 
(Epshtein et al. 2009) or by influencing the physical characteristics of the bilayer (Andersen & Koeppe 
2007). The ability of ion channels to associate with specific lipid domains is thus likely to be an 
important regulatory aspect of channel physiology (Dart 2010). 
One such physiological process is the membrane fusion (exocytosis) and fission (endocytosis) 
mechanisms underlying the Ca2+-dependent release of neurotransmitters and hormones (Ceccarelli & 
Hurlbut 1980, Henkel & Almers 1996). These processes are regulated by sphingosine and ceramide. 
Thus, ceramidase has been shown to regulate the trafficking and exocytosis of synaptic vesicles 
(Rohrbough et al. 2004) and sphingomielinase modulates dopamine release from mesencephalic 
neurons (Blochl & Sirrenberg 1996) and PC12 cells (Jeon et al. 2005) as well as glutamate release 
from developing cerebellar neurons (Numakawa et al. 2003). Furthermore, sphingosine-1-phosphate 
(S1P) is involved in glutamate release from hippocampal neurons (Kajimoto et al. 2007) and 
facilitates spontaneous transmitter release at the frog neuromuscular junction (Brailoiu et al. 2002). 
Also, sphingosine activates synaptic vesicle exocytosis (Darios et al. 2009) and enhances exocytosis 
and endocytosis in bovine chromaffin cells (BCCs) (Rosa et al. 2010). 
Glycolipids are sugar-attached lipids that are predominantly located in the outer plasmalemma layer. 
Their sulfation introduces negative charges that are determinants for interactions with proteic receptors 
and ion channels. They contribute to the regulation of myriad physiological functions such as cell 
differentiation, development, immune responses, cell adhesion, or blood clotting (Honke 2013) as well 
as to ion channel regulation (Dart 2010). Additionally, the sulfoglycolipid sulfatide plays a critical role 
in the regulation of oligodendrocytes  differentiation and the maintenance of myelin and axonal 
structure (Marcus et al. 2006). It also contributes to the stabilization of the axoglial junction between 
the myelin loop and the axolemma at the paranode region (Girault & Peles 2002) as well as to the 
location of Na+ and K+ channels in this region (Ishibashi et al. 2002). Altered sphingolipid metabolism 
has been found in some sphingolipidoses, diabetes, atherosclerosis, and cancer (Delgado et al. 2007). 
Furthermore, changes in brain levels of sulfatides have been recently reported to occur in patients with 
early Alzheimer’s disease (Han et al. 2002). These findings have been the starting point for an 
increased interest in drug development to interfere with sphingolipid metabolism to treat those 
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diseases. In this context, during the last years our laboratory has been engaged in the synthesis of 
various families of glycolipids and sulfoglycolipids that exhibit antimitotic activity in melanoma and 
glioma cells (Garcia-Alvarez et al. 2007, Doncel-Perez et al. 2013).  
Recently, we synthesized a new family of sulfoglycolipids that promote neuritic growth and 
myelination and additionally, they act as inhibitors of astroglia and microglia proliferation (Nieto-
Sampedro et al. 2012). The lead of this family is compound IG20, a sulfoglycolipid with a molecular 
structure that reminds that of endogenous sulfatide (Fig. 1). The present work was planned to test the 
hypothesis that IG20 could regulate the exocytotic release of neurotransmitters, as done by its parent 
endogenous lipidic compounds described above. We found that indeed, IG20 enhanced the release of 
catecholamines from BCCs through an exocytotic mechanism that depended on extracellular Ca2+. 
This response was due to cell depolarization and the firing of action potentials that augmented 
cytosolic Ca2+ concentrations ([Ca2+]c) and the exocytotic release of catecholamine. Theses effects 
seemed to be plasmalemmal-delimited because fluorescent IG20 was markedly confined to the cell 
membrane.  
 
EXPERIMENTAL PROCEDURES 
Isolation and culture of bovine chromaffin cells 
All experiments were carried out in accordance with the guidelines established by the National 
Council on Animal Care and were approved by the local Animal Care Committee of the Universidad 
Autónoma de Madrid in accordance with the code of ethics and guidelines established by European 
Community Directive (2010/63/EU) and Spanish legislation (RD53/2013). Adrenal glands were 
obtained from a local slaughterhouse under the supervision of the local veterinary service. Chromaffin 
cells were isolated as decribed (Moro et al. 1990). Cells were suspended in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 5% fetal bovine serum, 50 IU/mL penicillin and 50 
µg/mL streptomycin. For catecholamine release measurements from cell populations, cells were plated 
on 5-cm diameter Petri dishes at 5x106 cells per dish. For studies of patch-clamp, changes in [Ca2+]c, 
amperometry, and fluorescent IG20, cells were plated on 1-cm-diameter glass coverslips (Labbox, 
Barcelona, Spain) at low density (5×104 cells per coverslip). Cultures were maintained in an incubator 
at 37 °C in a water-saturated atmosphere with 5% CO2. Cells were used 1–4 days after plating. All 
experiments in this study were performed at room temperature (24 ± 2oC). 
 
Online amperometric recording of quantal catecholamine release at the single-cell level 
Carbon fibre microelectrodes were built and calibrated as previously described (Machado et al. 2008). 
The potentiostat was homemade (UAM workshop, Madrid, Spain) and was connected to an interface 
(PowerLab/4SP, ADInstruments, Oxford, UK) that digitised the signal at 10 kHz sending it to a 
personal computer that displayed it within the Pulse v8.74 software (HEKA Elektronik). A 700 mV 
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potential was applied to the electrode with respect to an AgCl ground electrode. The coverslips were 
mounted in a chamber on a Nikon Diaphot inverted microscope used to localise the target cell, which 
was continuously perifused by means of a five-way perifusion system with a common outlet driven by 
electrically controlled valves, with a Tyrode solution composed of (in mM) 137 NaCl, 1 MgCl2, 5 
KCl, 2 CaCl2, 10 HEPES and 10 glucose (pH 7.4, NaOH). The high K+solutions were prepared by 
replacing equiosmolar concentrations of NaCl with KCl. At the time of experiment performance, 
proper amounts of drug stock solutions were freshly dissolved into the Tyrode solution. These 
experiments were performed on cells from 1 to 4 days after culture. 
 
Online amperometric recording of burst catecholamine release from perifused populations of 
BCCs 
Cells were scrapped off carefully from the bottom of the Petri dish (5 × 106 cells per dish) with a 
rubber policeman and centrifuged at 120xg for 10 min. The cell pellet was resuspended in 200 µl of 
Krebs-HEPES solution (composition in mM: 144 NaCl, 5.9 KCl, 1.2 MgCl2, 2 CaCl2, 11 glucose, and 
10 HEPES, pH 7.3 with NaOH). Cells suspended were trapped in a microchamber and perifused at a 
rate of 2 ml/min. The liquid flowing from the perifusion chamber reached an electrochemical detector 
model VA 641 (Metrohm, Herisau, Switzerland) placed just at the outlet of the microchamber, which 
monitors online the amount of catecholamine secreted under the amperometric mode. This 
amperometric strategy permits the online recording of reproducible catecholamine release responses 
during long time periods of 30–60 min. Catecholamines are oxidised at +0.65 V and the oxidation 
current was recorded on a PC computer (Borges et al. 1986). 
 
Measurement of calcium in single-cells with fura-2AM 
To measure the changes in [Ca2+]c BCCs were incubated in DMEM containing the calcium probe fura-
2 acetoxymethyl ester (fura-2AM; 10 µM) for 1 h at 37 °C. After this incubation period, the coverslips 
were mounted in a chamber and cells were washed with Tyrode solution. The setup for fluorescence 
recordings was composed of a Leica DMI 4000 B inverted microscope (Leica Microsystems; 
Barcelona, Spain) equipped with an oil immersion objective (Leica 40× Plan Apo; numerical aperture 
1.25). Once the cells were placed on the microscope, they were continuously perifused by means of a 
five-way perifusion system at 1 ml/min with a common electrically controlled valves with Tyrode 
solution. Fura-2AM was excited alternatively at 340 ± 10 nm and 387 ± 10 nm using a Küber CODIX 
xenon arc lamp (Leica). Emitted fluorescence was collected through a 540 ± 20 nm emission filter, 
and measured with an intensified charge coupled device camera. Fluorescence images (Hamamatsu 
camera controller C10600 Orca R2) were generated at 1-s intervals.  
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Whole-cell current recordings 
All recordings were obtained under the whole-cell mode of the patch-clamp technique in its 
perforated-patch configuration. To reach the perforated-patch configuration we used 100 mg/ml 
amphotericin B. For current recordings, the external cell perifusion solution had the following 
composition (in mM): 137 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, 10 Hepes (pH 7.4 with NaOH). 
Recording started when the access resistance decreased below 30 MΩ, which usually happened within 
10 min after sealing. Series resistance was compensated by 80% and monitored throughout the 
experiment. The external solutions were rapidly exchanged using electronically driven miniature 
solenoid valves (The Lee Company, Westbrook, CO) coupled to a multi-barrel concentration-clamp 
device with a common outlet. The flow rate was 1 ml/min and was regulated by gravity.  
The intracellular solution used for the recording of inward Na+ currents (INa) and Ca2+ current (ICa) 
contained (in mM): 10 NaCl, 100 Cs-glutamate, 20 TEA, 14 EGTA, 5 Mg-ATP, 0,3 Na-GTP, 20 
HEPES (pH 7,2 with CsOH). For recordings of outward K+ currents (IK), the intracellular 
solution used contained (in mM): 120 K-glutamate, 10 NaCl, 20 HEPES, 14 EGTA, 5 Mg-
ATP, and 0,3 Na-GTP (pH 7.2 with KOH).  Electrophysiological data on ion currents were 
acquired with an EPC-9 amplifier under the control of Pulse software (HEKA Elektronik).  
To monitor the resting membrane potential (Vm), recordings were made under the current-clamp 
mode of the patch-clamp technique. Only cells with their initial resting Vm between -50 and -80 mV 
were tested. We considered that the cell was healthy when a depolarization above -50 mV fire some 
action potentials. The pipette-filling solution was as for IK recording. 
 
Experiments with fluorescent IG20-NBD 
We used confocal microscopy with green light (480-510 nm) to visualize cells exposed to IG20-NBD 
and blue light (350-461 nm) to see the nuclear probe Hoechst. Then, we first preincubated the cells 
with Hoechst for 5 min so we could focus the microscope and after that, we applied 10 µM IG20-NBD 
dissolved in Tyrode solution; at the same time we took sequential images in the Z-axis. The setup for 
fluorescence recordings was composed of a Leica TCS SP2 confocal microscope with a x100 
objective (spatial resolution based in this objective and the scanner characteristics was estimated in 
60–80 nm for 2–3 pixel separations). This system allows for z-axis reconstruction with theoretical z 
slice of about 0.5 mm thick and sequential mode studies in double labeling experiments.  
 
Statistical analysis 
Analysis of amperometric recordings from single BBCs was carried out using IgorPro software 
(version 4.0.8; Wavemetrics, OR, USA). A rule was drawn at 10 pA, and only the spikes going above 
the threshold amplitude were considered. Total amperometric quantal charge (calculated by integrating 
the amperometric current over time during the stimulus duration) and the number and area of 
individual amperometric spikes > 10 pA were calculated by using a macro written in IgorPro software 
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(Mosharov & Sulzer 2005).  
Data analysis of amperometric recordings in BBC populations (peak amplitudes in nA or areas in pC) 
were performed using Origin Pro software (version 8.6; OriginLab Corporation, Northampton, MA, 
USA). Results are expressed as mean ± SEM throughout. 
Data analysis of ion currents and cell excitability were performed using the GraphPad Prism (version 
5.01; GraphPad Software, San Diego, CA, USA).  
Student’s t-test was used to determine statistical significance between means when n values followed a 
normal distribution. When n values were non- parametric Mann-Whitney test was used. *P < 0.05 was 
taken as the limit of significance; ** and *** show a statistical significance of P < 0.01 and P < 0.001, 
respectively. 
 
Materials and chemicals 
IG20 was synthesized at our laboratories as previously described (Garcia-Alvarez et al. 2007); the 
compound was dissolved in distilled water, and 10 mM stock solution was stored in aliquots at -20ºC. 
The synthesis of fluorescent IG20-NBD started with a Fisher-type glycosylation of N-trifluoro-acetyl-
D-glucosamine (Wolfrom & Conigliaro 1969) with oleic alcohol followed by regioselective sulfation 
using SO3-pyridine complex. Removal of trifluoroacetyl group and subsequent amidation reaction 
with acid (Ludolph & Waldmann 2003), bearing a C6 linker and the NBD fluorophore, lead to IG20-
NBD, that was dissolved in DMSO and stored at the concentration of 10 mM at -20ºC. DMEM and 
nifedipine were purchased from SIGMA-Aldrich (Madrid, Spain). The calcium binding probe fura-
2AM was purchased from Invitrogen (Eugene, OR, USA). Thapsigargin was purchased from Abcam 
Biochemicals® (Cambridge, UK).   
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RESULTS 
IG20 augments basal secretion and K+-elicited secretion in populations of BCCs 
BCCs (5×106) trapped in a microchamber and perifused at 2 ml/min with a saline solution containing 2 
mM Ca2+, revealed a stable rate of basal catecholamine release at around 10-20 nA. When challenged 
with a 35K+- solution (saline containing 35 mM K+, low Na+, 2 mM Ca2+) given for 10 s every 3 min, 
cells responded with a transient surge of catecholamines that depending on the cell batch and culture, 
varied between 200 and 600 nA spike amplitudes. However, within the same batch of cells, repeated 
35K+ pulses gave rise to quite reproducible spike responses along periods of 30-60 min. This 
permitted the exploration of the effects of a given IG20 concentration within the same cell batch, by 
giving first a set of 35K+ pulses (control responses) followed by another set in the presence of the 
compound, and a final set after its washout. At 1 µM, IG20 caused a tiny elevation of such basal 
secretion and a gradual increase of the 35K+ responses that although they gradually declined, they 
however remained elevated by the end of the experiment (Fig. 2A). At 3 and 10 µM, IG20 caused 
more pronounced elevations of basal secretion and superimposed on this, a gradual potentiation of the 
35K+ responses was once more observed (Fig 2B,C). The instauration of these responses and their 
reversal were also gradual. Pooled normalized data indicated a concentration-dependent effect of IG20 
in enhancing the 35K+ responses (Fig. 2D). 
Effects on basal secretion were further explored by cell exposure to IG20 under resting conditions and 
between two sets of 35K+ pulses. Of interest was the pronounced elevation of basal secretion after a 30 
s delay of adding 10 µM IG20, and the considerable enhancement of the 35K+ responses following its 
washout (Fig. 2E). Pooled results graphed in Fig. 2F show that areas of the basal secretion curves in 
µC were augmented by 3 and 10 µM IG20 in a concentration-dependent manner. 
Next we explored whether IG20 elicited the same or distinct relative potentiation of the K+-responses 
when cells were challenged with different K+ concentrations, namely 17.7 mM (17.7K+), 35 mM 
(35K+), or 100 mM (100K+). Fig. 3A,B,C shows example records of the K+-elicited secretion 
transients before and during cell perifusion with 10 µM IG20. Note the elevation of basal secretion 
and superimposed on it, the enhanced K+ secretory responses. Averaged data plotted in Fig. 3D show 
that the potentiation by 10 µM IG20 of the K+-elicited secretion depended on its concentration, 4.7-
fold at 17.7 mM K+, 2.8-fold at 35 mM, and 1.6-fold at 100 mM. 
 
IG20 augments the rate of basal quantal catecholamine release and potentiates the K+-elicited 
secretion at the single-cell level 
 On-line recording of single-vesicle release of catecholamine was monitored with a carbon fibre 
microelectrode placed onto the surface of a single BCC and connected to an amperometer. Upon a few 
minutes of cell perifusion with a saline solution containing 2 mM Ca2+, spontaneous spikes were rarely 
seen (Fig. 4A); this example cell, however, responded with a spike burst upon the application of a 
35K+ challenge at the end of the experiment, indicating its viability. The cell of Fig 4B was initially 
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stimulated with a 35K+ pulse. IG20 (10 µM) was given 2 min before the application of the second 
35K+ pulse; after a delay of about 30 s the cell begun to fire secretory spikes at increasing frequency 
that subsequently decreased. Of note was the drastic potentiation of secretion evoked by the second 
35K+ challenge (that was applied immediately after IG20 removal) with respect the initial 35K+ pulse. 
In the cell of Fig. 4C, IG20 was applied for a short period of time (30 s) to prevent the alteration of 
basal secretion. When the second 35K+ pulse was applied on top of IG20, a notable potentiation of 
secretion was produced, in comparison with the first and third 35K+ pulses.  
Cumulative basal secretion calculated as the number of spikes present in 5-s segments of the traces, is 
graphed in Fig. 4D; while spikes were practically absent in control cells, those exposed to 10 µM IG20 
begun to fire secretory spikes after an initial delay of about 20 s, that reached a plateau of about 30 
spikes after 2 min. IG20 also augmented the 35K+ responses from 10 to about 15 spikes (Fig. 4E). 
 
Effects of tetrodotoxin, nifedipine, cadmium and thapsigargin on IG20 elicited secretion  at the 
single-cell level 
The removal of Ca2+ from the saline solution perifusing the cell of Fig. 5A during 3 min, and its 
subsequent perifusion for an additional 3-min period with saline solution containing 2 mM Ca2+, did 
not generate any secretory activity. This cell was viable, as proven by the burst of spikes produced by 
a 35K+ pulse given at the end of the experiment. The cell of Fig. 5B was subjected to a similar 
protocol but with a major difference: it was initially perifused with a saline solution deprived of Ca2+ 
but containing 10 µM IG20. The switching of this solution to another containing 2 mM Ca2+ (but not 
IG20) immediately generated a sharp and sustained secretory response that gradually declined along 
the 3-min period of Ca2+ reintroduction. The cell of Fig. 5C was subjected to a similar protocol with a 
new element namely, the presence of 3 µM nifedipine in both the Ca2+-free and the Ca2+-containing 
saline solutions. Under these conditions, the simultaneous exposure to nifedipine and IG20 during the 
period of perifusion with Ca2+-free saline, abolished the later secretory response elicited by Ca2+ 
reintroduction. Pooled data summarized in Fig. 5D indicate that the total secretion elicited by Ca2+ 
reintroduction in cells previously exposed to IG20 was abolished by 200 µM Cd2+ or 3 µM nifedipine, 
suggesting that such response was due to Ca2+ entry through voltage-activated calcium channels 
(VACCs) of the L-subtype (α1D, Cav1.3). 
We also tested the effects of tetrodotoxin (TTX; 1 µM) on the secretory effects of IG20 added to a 
saline solution containing 2 mM Ca2+. Under these conditions, the control secretory effects of IG20 
during 2 min of cell perifusion were 18.5+4.4 spikes and 14.6+8.4 pC of total secretion. TTX reduced 
by about 90% this response (Fig. 5E). 
Whether the endoplasmic reticulum (ER) Ca2+ store contributed to the secretory effects of IG20 was 
explored using thapsigargin to deplete such store. Cells were perifused with a saline solution 
containing 2 mM Ca2+ and 1 µM thapsigargin for 5 min. Then IG20 was given in a solution containing 
Ca2+ but no thapsigargin (this compound is known to irreversibly block the sarco-endoplasmic 
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reticulum Ca2+ ATPase (SERCA; (Lytton et al. 1991)). Fig. 5F shows that total secretion elicited by 
IG20 in control cells (37.3+5.8 pC) was reduced to 27.1+7.1 pC in cells pretreated with thapsigargin; 
this reduction, however, did not reach the level of statistical significance.   
 
Effects of IG20 on cytosolic calcium concentrations 
The secretory response elicited by Ca2+ reintroduction in BCCs exposed to IG20 should be 
accompanied by an elevation of [Ca2+]c. This was tested in single BCCs loaded with fura-2AM. The 
two example cells of Fig. 6A initially responded with sharp transient elevations of [Ca2+]c upon their 
challenging with a 5-s 35K+ pulse. After baseline recovery, the control cell in panel A was perifused 
during 6 min with 0Ca2+ saline solution while the cell in panel B was perifused with this same solution 
during 3 min followed by another 3-min period with Ca2+-free solution containing 10 µM IG20. Then, 
Ca2+ at 2 mM was reintroduced; this evoked a tiny elevation of basal [Ca2+]c in the control cell, while a 
pronounced elevation of [Ca2+]c was produced in the cell previously exposed to IG20. Pooled results 
of cells subjected to this protocol, normalized as % of the initial 35K+ responses, are graphed in Fig. 
6C. Both, the mean amplitude and area of the [Ca2+]c responses were augmented 2.5- and 3-fold in the 
cells exposed to IG20, with respect control cells. 
The possible contribution of Ca2+ release from the ER store was tested in a second series of 
experiments that included control cells and other cells treated with 1 µM thapsigargin applied during 
the period in between the initial 35K+ pulse and the final application of 10 µM IG20. These cells were 
perifused with saline containing 2 mM Ca2+ along the experiment. The cell of Fig. 6D responded with 
an initial sharp [Ca2+]c transient upon 35K+ stimulation; the [Ca2+]c had recovered baseline when IG20 
perifusion generated an initial fast [Ca2+]c elevation that later on rose more slowly to reach a peak and 
then slowly decline. The cell in Fig. 6E equally responded to 35K+ with a sharp [Ca2+]c transient; its 
subsequent exposure to 1 µM thapsigargin produced a mild but sustained elevation of basal [Ca2+]c due 
to ER Ca2+ release and ER Ca2+ depletion (Rasmussen et al. 1978). The subsequent addition of IG20 
produced a [Ca2+]c transient that gradually rose to a peak and then decayed. Pooled normalized data 
graphed in Fig. 6F shows that IG20 caused 1.5-fold higher increase of the Ca2+ peak amplitude and 
2.5-fold higher increase of the [Ca2+]c area in thapsigargin-treated cells, with respect to control cells. 
We also made experiments with the application first of a K+ pulse and then after 3 min to allow 
baseline recovery, IG20 was applied for 1 min and another K+ pulse was applied. Although peak 
[Ca2+]c transients were unchanged, IG20 elicited a 1.5-fold increase of the normalized [Ca2+]c area 
(0.99±0.1 in the control K+ challenge and 1.49±0.13 in the K+ challenge after IG20 treatment; n=18 
cells, P<0.05). 
 
Effects of IG20 on cell excitability and ion channel currents 
Blockade of the secretory effects of IG20 elicited by Cd2+ and nifedipine suggests that Ca2+ entry 
through L-subtype of VACCs is implicated in such response. The opening of these channels requires 
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membrane depolarization and thus, it was predicted that IG20 had the potential to cause cell 
depolarization. This was tested using the perforated-patch configuration of the patch-clamp technique 
under the current-clamp mode. 
The initial resting membrane potential (Vm) of the example BCC shown in Fig. 7A was about -80 
mV. No spontaneous action potentials were observed, a property typical of BCCs (Orozco et al. 2006). 
After a delay of about 2 min, IG20 at 10 µM began to depolarize the cell to reach a plateau at about -
40 mV. Superimposed on this plateau, a discharge of intermittent action potentials was produced. At 
an expanded scale these action potential exhibited an overshoot at around 10 mV and the typical 
afterhyperpolarisation. Pooled data from 9 BCCs (Fig. 7B) indicated an initial Vm  of -70+8 mV; the 
resting Vm was reduced to -40+5 mV in the presence of IG20 (p<0.001). Of interest was an 
experiment performed in current-clamped cells showing that TTX (1 µM) did not affect the 
depolarizing effect of IG20 (Fig. 7B). 
To inquire into the possible mechanism underlying the depolarizing effect of IG20, a study of the 
whole-cell currents through Na+ channels (INa), VACCs (ICa), and K+ channels (IK) was performed 
using the perforated-patch configuration of the patch-clamp technique under the voltage-clamp mode. 
Fig. 7C shows two INa traces generated by test depolarizing pulses to -30 mV, applied from a holding 
potential of -80 mV. After 30-s of cell perifusion with 10 µM IG20, INa amplitude increased near 3-
fold. The complete I-V curves for INa averaged from 18 cells are graphed in Fig. 7D. Control INa had a 
threshold potential at -50 mV, peaked at -10 mV, and had a reversal potential at around +70 mV. In 
the presence of IG20 the current amplitude increased at hyperpolarising voltages in such a manner that 
in the range -50 to -10 mV the I-V curve was shifted to the left by around 10 mV and the peak current 
was significantly enhanced by 133%  at -40 mV, 89% at -30 mV, and 30% at -20 mV. 
Fig. 7E shows example paired ICa traces obtained from BCCs voltage-clamped at -80 mV, using 2 mM 
external Ca2+ as charge carrier. ICa traces generated by test pulses to 0 mV were quite similar before 
and during cell perifusion with 10 µM IG20. Overlapping full I-V curves plotted in Fig. 7F exhibit a 
threshold voltage for ICa activation at -40 mV, with peak current at around -10 mV and a reversal 
potential at around +60 mV. 
The effect of IG20 on IK was explored in cells voltage-clamped at -80 mV and stimulated with a two-
steps depolarizing pulse, first to 10 mV for 10 ms and subsequently to +120 mV for 400 ms. The first 
step served to stimulate Ca2+ entry and activate the Ca2+-dependent component of IK (mostly due to 
BK channels in BCCs) (Marty & Neher 1985). Thus, with this protocol (Fig. 8A) we could study 
within the same cell the voltage-dependent component of IK (IK(V)) and its Ca2+-dependent component 
(IK(Ca)). Fig. 8B shows two example IK traces obtained in a BCC before (control) and during its 
perifusion during 1 min with 10 µM IG20; the IK(Ca) was enhanced by IG20 while the IK(V) was 
unaffected. The time course for the effects of IG20 on IK(Ca) of the cell of Fig. 8B is displayed in Fig. 
8C; IG20 augmented gradually this current component to reach a plateau after a minute. Quantitative 
data from 12 cells are graphed in Fig. 8D. Normalised peak IK(Ca) was augmented by 25% in the 
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presence of IG20 (p<0.001). Paxilline (1 µM), a selective blocker of BK channels (Knaus et al. 1994) 
counteracted the potentiating effect of IG20 and further reduced IK(Ca) by 25%  with respect to control. 
IK(Ca) was further reduced by 200 µM Cd2+ to 60+4% of control (Fig. 8D). 
 
 
Insertion of fluorescent IG20 into the plasmalemma 
Sulfoglycolipid IG20 contains a polar sugar moiety containing a negatively charged OSO3- group with 
an oleoyl lipophilic chain (Fig. 1). This chain may favour its insertion into the plasmalemma; 
nevertheless, the polar moiety may preclude its penetration into the cell. This was tested with the 
fluorescent derivative IG20-NBD. Worth of note is the fact that this compound triggered 
catecholamine release at the single-cell level, very much as the parent compound IG20 did (data not 
shown).  
We first performed experiments to study the time course of plasmalemmal staining with IG20-NBD. 
Fig. 9A displays a temporal sequence of confocal micrographs taken from a BCC before its exposure 
to IG20-NBD (10 µM) and at different times of cell exposure to the compound. A tiny fluorescent 
labelling of the plasmalemma was apparent after 1.20 min, exhibiting a patchy distribution of IG20-
NBD. This patchy accumulation of IG20-NBD was gradually growing with exposure time to the dye, 
to reach near confluence at 8 min. In two additional experiments done with different cell batches, cells 
with a clear-cut patchy ring alternated with others showing more diffuse fluorescence.  
Fig. 9B shows a Z-axis sequence of confocal images taken from a BCC after 8 min exposure to 10 µM 
IG20-NBD. From top to bottom, images clearly show that fluorescence is located at the plasmalemma, 
showing a nitid ring at intermediate equatorial planes. The thick fluorescence ring observed in some 
regions (around 2 µm) could be due to IG20 being incorporated gradually into the cell through an 
endocytotic mechanism. Disperse fluorescence spots were seen at the bottom planes, probably due to 
the area of contact of the cell with the glass coverslip.  
 
 
DISCUSSION 
Central in this study was the finding that the novel synthetic sulfoglycolipid IG20 triggered the release 
of catecholamine from BCCs. This was true in experiments done in cell populations (Fig. 2E,F) as 
well as in those executed at the single-cell level (Fig. 4B). This release was surely exocytotic in nature 
because it was abolished in Ca2+-free saline and re-established upon Ca2+ reintroduction (Fig. 5B). 
Ca2+ entry was required for the IG20 secretory effects and this was achieved through the VACC 
pathway, as indicated by its suppression with Cd2+ (Fig. 5D). BCCs express L- as well as N-, and PQ-
subtype of VACCs (Garcia et al. 2006) and thus the question arose on whether all channel subtypes 
contributed to the IG20 secretory effects. The fact nifedipine caused a drastic inhibition of the 
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response (Fig. 5C,D) indicated L channels were the preferred Ca2+ entry pathway triggering exocytosis 
from BCCs exposed to IG20. An explanation for this may rest in the fact N and PQ channels promptly 
inactivate upon BCCs depolarisation, while L channels do not (Villarroya et al. 1999). 
The prompt increase of basal secretion upon addition of IG20 (Fig. 2B,C) seems apparently 
contradictory with the longer duration of the potentiating effects of the compound on the K+ responses 
(Fig. 3B). It is also puzzling that during IG20 perifusion, the enhanced basal secretion was gradually 
decaying yet the potentiated K+ response remained (Figs. 2B and 3B). This could find an explanation 
in the fact K+-elicited [Ca2+]c elevations are contributed not only by Ca2+ entry through VACCs but 
also by Ca2+-induced Ca2+ release in BCCs (Alonso et al. 1999). This additional factor may not be 
present in the case of IG20 that causes a milder [Ca2+]c elevation in comparison with K+ (Fig. 6B). 
IG20 triggered secretion by itself and additionally, the compound also augmented the response elicited 
by depolarising K+ solutions both in cell populations (Fig. 2D) an at the single-cell level (Fig. 4C,E). 
The fact such potentiation was lesser the greater the K+ concentration (Fig. 4D), indicated that IG20 
itself could be eliciting cell depolarisation, thus explaining its ability to stimulate Ca2+ entry through L 
channels. These depolarising effects with superimposed action potentials were clearly demonstrated by 
the current-clamp experiments summarised in Fig. 7A,B. 
More complicated could be to find the mechanism underlying the depolarising action of IG20. For 
instance, Na+ channel modulation in cardiac myocytes elicited by agonists of α1-adrenergic receptors 
or general anaesthetics such as halothane develop slowly and is  mediated by intracellular messengers 
(Terzic et al. 1993, Weigt et al. 1998). In this study, the drastic blockade of secretion by TTX (Fig. 
5D) strongly suggests that voltage-activated Na+ channels are involved in the secretory effects of 
IG20. This is supported by the observation that IG20 shifted the I-V curve for INa to the left (Fig. 7D), 
implying that Na+ channels were more prone to be opened at more hyperpolarising potentials. At the 
end, this effect could remind that of veratridine that also augments the fraction of Na+ channel opening 
but through a different mechanism namely, the delay of Na+ channel inactivation (Ota et al. 1973). 
This augments Na+ entry into BCCs (Kilpatrick et al. 1981), causes cell depolarisation (Lopez et al. 
1995), opening of VACCs, increased Ca2+ entry (Kilpatrick et al. 1981), [Ca2+]c oscillations (Maroto et 
al. 1994, Maroto et al. 1996, Lopez et al. 1995, Novalbos et al. 1999), and augmented secretion 
(Kilpatrick et al. 1981, Conceicao et al. 1998). However, IG20 did not elicit [Ca2+]c oscillations (Fig. 
6) neither it caused delayed inactivation of Na+ channels (not shown). Thus, although at the end it 
causes cell depolarisation, enhanced Ca2+ entry and secretion as veratridine do, nevertheless IG20 
could have those effects through a different mechanism namely, the opening of Na+ channels at more 
hyperpolarising potentials. However, this sole action may not explain the depolarising effect of IG20 
because it was not affected by TTX (Fig. 7B). An alternative explanation is that in addition of shifting 
the fast-inactivating Nav channels expressed by CCs (Nav1.3 and Nav1.7; (Vandael et al. 2015a, 
Vandael et al. 2015b), IG20 may activate some non-inactivating Na+ channel which may sustain 
resting Vm and thus cause cell depolarization. 
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Although IG20 is water soluble, its long lipidic chain could facilitate its insertion into the plasma 
membrane (Fig. 1). On the other hand, its polar sulphated D-glucopyranoside moiety (Fig. 1) 
precluded its penetration into the cell cytosol, thus remaining confined to the cell plasma membrane as 
illustrated by the experiments with fluorescent IG20-NBD (Fig. 9). This insertion of IG20 into the 
plasmalemma was time dependent, suggesting that the compound underwent a gradual accumulation 
(Fig. 9A). This is compatible with the secretory effects of IG20 at the single-cell level that were 
initiated after 30 s and developed gradually along a 2-3 min perifusion period (Fig. 4D). Also, in cell 
populations the potentiation of the secretory responses elicited by K+ developed gradually (Fig. 2B). 
This was also the case for the gradual augmentation of IK elicited by IG20 (Fig. 8C). Another 
observation compatible with the stable insertion of IG20 into the plasmalemma was the slow 
reversibility of its effects upon its washout for instance, on secretion at the single-cell level (Fig. 5C). 
This was also observed in current-clamp experiments where IG20 elicited a gradual depolarisation that 
reversed very slowly upon its washout (Fig. 7A). 
One may consider that a sulfoglycolipid such as IG20 that is inserted into the plasmalemma, could 
behave as an ionophore such as A23187 or even as a detergent such as digitonin. However, the 
reversible augmentation of catecholamine release (Figs. 2E, 4B), the potentiation of K+-elicited 
secretion (Figs. 3D, 4E), the blockade of such responses by nifedipine and cadmium (Fig 5D), the 
partial depolarization elicited by IG20 in current-clamped cells (Fig. 7D), all require an intact 
hyperpolarized plasma membrane which is incompatible with the concept of ionophore or detergent. 
Furthermore, the reversibility of the effects and the fact the K+ secretory response after a period of 
IG20 remains intact (Fig. 5C), further strengthen our view that in BCCs IG20 does not act as an 
ionophore or detergent chemical. 
The plasmalemmal accumulation of IG20 could modify the rearrangement of endogenous lipids to 
regulate, for instance, the availability of Na+ channels and increase their opening probability at more 
depolarising potentials (Fig. 7D). This is in line with some observations on the regulation of lipid 
rearrangement of various subtypes of Na+ channels. For instance, the stimulation of β-adrenergic 
receptors in the heart augments current density through Na+ channels of the Nav1.5 subtype, as a result 
of an interaction with the lipid raft caveolin-3; this lipid raft protein promotes the recruitment of 
Nav1.5-containing caveolae to the surface membrane (Balijepalli & Kamp 2008, Dart 2010). Two 
additional examples are the trafficking of epithelial Na+ channels (ENaC) to the apical membrane in 
lipid rafts, in cells of mouse cortical collecting ducts (Hill et al. 2007) and the regulation of the activity 
of those channels by caveolin (Lee et al. 2009). Finally, mouse ventricular myocytes form a 
macromolecular signalling complex with caveolin-3 and a number of signalling molecules of the β-
adrenergic receptor pathway (Balijepalli et al. 2006, Calaghan & White 2006). 
Lipid regulation of large-conductance voltage- and Ca2+-activated K+ channels (BK; KCa1.1) has also 
been documented. Thus, in smooth muscle cells of rabbit pulmonary arteries, BK channels are 
activated by arachidonic acid and miristic acid (Kirber et al. 1992). Furthermore, fatty acids and 
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negatively charged single-chain lipids decrease their activity (Clarke et al. 2003). Additionally, 
docosahexaenoic acid (Hoshi et al. 2013) and cerebrosides (Zhang et al. 2014) directly activate BK 
channels. Exogenous IG20 could mimick the effects of these endogenous lipids to enhance IK(Ca)  in 
BBCs (Fig. 8). The resting Vm in mouse and rat CCs is set by K+ channels that are not the BK. For 
instance, TASK1 (Inoue et al. 2008) and SK channels (Vandael et al. 2012) are proven to set the 
resting Vm and action potentials of CCs. Modulation of those channels by IG20 (and by endogenous 
lipids, as commented above), could explain the initial depolarising effects of IG20. 
The scheme of Fig. 10 summarizes the proposed sequence of steps underlying the mechanism 
involved in the exocytotic release of catecholamine from BCCs exposed to IG20: the compound 
inserts into the plasma membrane through its lipophilic moiety (1) but can not enter the cytosol 
because of its hydrophilic sulphate sugar moiety (2); this causes membrane depolarization by as yet 
undefined regulation of ion channels and the recruitment of Na+ channels at more hyperpolarising 
potentials (3) to elicit superimposed action potentials (4) that will cause the opening of VACCs of the 
L-subtype (5), augmented Ca2+ entry and the elevation of [Ca2+]c (6); this will finally lead to the 
exocytotic release of catecholamine (7) as well as to the activation of BK channels (8) that may be 
responsible of the afterhyperpolarisation of IG20-elicited action potentials (4). 
In conclusion, novel synthetic sulfoglycolipid IG20 triggers the secretion of catecholamine and 
potentiates the secretory response to K+ depolarisation. It seems this effect is initiated by a lipid type 
modulation of as yet undefined channels that causes Na+ channel recruitment and ensuing action 
potentials. Although at this stage we do not know how IG20 acts to enhance Na+ channel recruitment, 
its sulfoglycolipid nature indicates it could be mimicking the modulation of Na+ channel kinetics by 
lipid rearrangement at the plasma membrane upon cell stimulation. IG20 belongs to a new family of 
sulfoglycolipids synthesised at our laboratory that promote neuritic growth and myelination (Nieto-
Sampedro et al. 2012). Thus, it is plausible that the Ca2+ and exocytotic signals generated by IG20 here 
described, could contribute to the plasticity action of this sulfoglycolipid. In fact, preliminary results 
indicate that IG20 exerts neuroprotection in rat hippocampal slices challenged with veratridine, 
glutamate, or combined olygomycin-rotenone. Therefore, by mimicking and/or causing a 
redistribution of endogenous plasmalemmal sulfatide, an IG20-like sulfoglycolipid drug could  
represent a new therapeutic strategy to improve neurotransmission. This may find potential therapeutic 
applications in various CNS diseases where neurotransmission is impaired i.e. Alzheimer’s disease 
where altered endogenous sulfatide levels have been recently described at early disease stages  (Han et 
al. 2002). 
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FIGURE LEGENDS 
Figure 1. Biosynthetic pathway of endogenous sulfatide (B) from ceramide (A) and molecular 
structure of the synthetic sulfoglycolipid IG20 (oleoyl 2-N-acetyl-2-amino-2-deoxy-6-O-
(oxosulfonyl)-alpha-D-glucopyranoside)(C) 
 
Figure 2. IG20 augments the rate of basal catecholamine release and potentiates the K+-evoked 
release in populations of bovine chromaffin cells (BCCs). Cells trapped in a 
microchamber (5x106) were perifused at 2 ml/min with a Krebs-Hepes solution at room 
temperature. The rate of catecholamine release was amperometrically monitored online in 
the perifusion solution that passed through an electrochemical detector. Once baseline 
secretion stabilised, cells were challenged with 10-s pulses of a K+-enriched solution (35 
mM K+, low-Na+, 2 mM Ca2+; 35K+), applied at 3-min intervals. The release of 
catecholamine is expressed in the ordinates of the corresponding panels in nA of the 
current generated by the oxidation of the catecholamine. IG20 was present at the 
concentrations and during the time lapse indicated by the horizontal bars below each 
trace. D shows pooled data normalized as % of the pre-IG20 perifusion (C, control 
secretion during the third K+ pulse) in each individual batch of cells. Data are means + 
SEM of the number of cell batches (n) and cultures (N) shown in parentheses. *p<0.05, 
***p<0.001 with respect to control. E, example trace to illustrate the augmentation of 
secretion elicited by IG20 in the absence of 35K+ stimulation. F, total enhanced basal 
secretion elicited by IG20 (ordinate in µC). ***p<0.001 with respect to 3 mM IG20  
(Student t test).  
 
Figure 3. Greater facilitation of secretion elicited by IG20 when using lower K+ concentrations, 
with respect to higher K+ concentrations, in perifused BCC populations. Experimental 
protocols are as in Fig. 2C. A,B,C are original traces of experiments done with 17.7 mM 
K+ (17.7K+), 35 mM K+ (35K+), or 100 mM K+ (100K+), respectively, repeatedly applied 
during 10-s at 3 min intervals, as indicated by dots at the bottom of each trace. IG20 was 
applied during the time period indicated by the horizontal bars below each trace. D, 
pooled data on peak secretion normalized as 100% (control, C) of the response before 
adding IG20. Data are means + SEM of the number of cell batches (n) and cultures (N) 
displayed in parentheses. ***p<0.001 with respect to control (Student t test). 
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Figure 4. Effects of 10 µM IG20 on the spontaneous and K+-elicited secretory spike events 
monitored amperometrically at the single-cell level with a carbon fibre microelectrode. A, 
example record showing no spontaneous events during a 5-min period of cell perifusion 
with Tyrode containing 2 mM Ca2+, and the spike burst generated by the K+ pulse (35 
mM K+, low-Na+, 2 mM Ca2+) applied at the end of the experiment (bottom horizontal 
bar). B, example record obtained in a BCC showing the initial K+-evoked burst of 
secretory spikes over baseline elevation, the increasing number of spikes elicited by IG20 
after a 30-40 s delay (bottom horizontal line), and the spike burst generated by K+ at the 
end of the experiment. C, protocol similar to the experiment of panel B, showing the 
enhanced 35K+ secretion after 30-s pre-exposure to IG20. D, cumulative secretion 
expressed as spike number counted at 5-s intervals (ordinate) versus time (abscissa), in 
control BCCs and cells exposed to IG20. E, pooled data on the facilitation of IG20 of 
quantal secretion elicited by K+, expressed as cumulative spike number (ordinate) counted 
as in D. Data in D and E are means + SEM of the number of cells (n) and cultures (N) 
given in parentheses. Data passed the normality test so Student’s t-test was used. *p<0,05 
and **p<0.01with respect to control. 
 
Figure 5. Augmentation of basal secretion elicited by IG20 depends on Ca2+ entry through voltage-
activated Ca2+ channels (VACCs). As in Fig. 4, quantal catecholamine release from single 
BCCs was recorded with a carbon fibre microelectrode and amperometry. A, cell first 
perifused with a nominal Ca2+-free saline (0Ca2+) followed by 2 mM Ca2+ reintroduction 
(2Ca2+) and a final 35K+ pulse, as indicated by horizontal bars at the bottom. B, cell 
initially perifused with 0Ca2+ and IG20 and subsequently with 2Ca2+ in the absence of 
IG20 (bottom lines). C, cell perifused with nifedipine throughout, initially in 0Ca2+ and 
IG20 and then with 2Ca2+ plus nifedipine but not IG20, and a final 35K+ challenge in 
2Ca2+ without nifedipine. D, pooled results of experiments with the protocols A, B and C 
and additionally with other experiments using Cd2+ instead of nifedipine. E, secretory 
effects of IG20 (10 µM) given with saline containing 2 mM Ca2+ in the absence (control 
secretion) expressed as spike number and total secretion, or in the presence of TTX (1 
µM) given 1 min before and during the 2-min exposure to IG20. F, pooled data of 
experiments performed with cells pretreated with 1 mM thapsigargin in 2Ca2+ during 5 
min followed by IG20 treatment at 10 mM. Total secretion (ordinates) in D and E were 
calculated as the summatory of spike areas during the Ca2+ reintroduction period. Data in 
D and E are means + SEM of the number of experiments (n) and cultures (N) shown in 
parentheses. Data failed the normality test so Mann-Whitney test was used.*p<0.05, 
***p<0.001 with respect to control (Ca2+ reintroduction without any treatment). 
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Figure 6.  IG20 augments the cytosolic Ca2+ concentration ([Ca2+]c) in fura-2AM-loaded BCCs. 
These experiments were performed following protocols reminding those used to study 
secretion at the single-cell level (see Fig. 5). A, example fluorescence trace in a cell first 
challenged with a 35K+ pulse (35 mM K+, low Na+, 2 mM Ca2+) followed by a 6-min 
period of Ca2+ deprivation (0Ca2+) and Ca2+ reintroduction, as indicated by bottom 
horizontal bars. B, example trace in a cell with a protocol similar to A in which the 6 min-
period in 0Ca2+ had two parts: 3 min of initial perifusion in 0Ca2+ and 3 min in 0Ca2+ 
containing 10 µM IG20, as indicated; the Ca2+ was reintroduced in the absence of IG20 
(2Ca2+). C, pooled averaged data on peak and area of the [Ca2+]c elevations in control 
cells (C) and IG20-treated cells. D and E, example traces from two cells perifused with 
2Ca2+, first challenged with 35K+ pulses and subsequently perifused with Ca2+-containing 
saline in the absence (control) or the presence of 1 mM thapsigargin, and finally exposed 
to IG20, as indicated by the bottom horizontal bars. F, pooled results from experiments as 
those in D and E, on peaks and areas of the [Ca2+]c elevations produced by IG20 in 
control cells (D) and thapsigargin-treated cells (E). Data in panels C and F were 
normalized as % of the initial K+ response within each cell; they are means + SEM of the 
number of cells indicated in parentheses. *p<0.05, ***p<0.001 with respect their 
respective control Data did not fit D’Agostino and Pearson normality test so the Mann-
Whitney test was used. 
 
Figure 7.  IG20 causes cell depolarization and shifts the I-V curves for Na+ currents (INa) to the left, 
but does not affect Ca2+ currents (ICa). These experiments were performed with the patch-
clamp technique under the perforated-patch configuration. A, original trace on the 
membrane potential (Em) of a current-clamped BCC, exposed to IG20 during the time 
period indicated by the top horizontal bar. B, pooled data on the depolarizing effects of 
IG20 (ordinate, in mV) and the lack of effect of TTX (1 mM) on this depolarisation. C, 
original whole-cell INa current traces obtained from a BCC before (control) or 30 s after 
IG20 perifusion, using the voltage-clamp protocol shown on the top. D, pooled results of 
I-V curves for INa (ordinate) obtained with sequential series of test depolarising pulses 
given in 10 mV steps (abscissa). E, original ICa current obtained from a voltage-clamped 
cell before and 30 s after IG20 exposure, generated by applying the protocol shown on 
the top. F, pooled data on I-V ICa curves generated by sequential application of 
depolarising pulses to voltage-clamped cells, given at 10-mV steps (abscissa). Data in B, 
D, and F are means ± SEM of the number of experiments and cultures shown in 
parentheses. **p < 0.01 and *** P < 0.001 with respect to basal or control. 
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Figure 8.  IG20 augments the Ca2+-dependent component of the whole-cell K+ current (IK(Ca)), but 
not the voltage-dependent component (IK(V)) in voltage-clamped BCCs. A, protocol used 
to stimulate the cells. B, IK currents with their Ca2+-dependent and voltage-dependent 
components before (control) and 2 min after exposure to IG20. C, time course of IK in an 
example cell before (control) and in the presence of IG20. D, pooled results of data from 
BCCs exposed to IG20 alone, or in the presence of 1 µM paxilline or 100 mM Cd2+. Data 
are means ± SEM of the number of cells and cultures indicated in parentheses.  
 
Figure 9. Fluorescent IG20-NBD accumulates in the plasma membrane and does not penetrate into 
BCCs. A, Time course of IG20-NBD (10 µM) accumulation into the plasma membrane 
of a cell before (pre-application, top image) and during its application during the times 
shown in each fluorescence micrograph using fluorescence confocal microscopy. B, 
sequential confocal microscopy images (left to right, top to bottom) taken on the Z axis, 8 
min after cell incubation with IG20-NBD.  Note the nitid accumulation of fluorescence at 
equatorial planes. 
 
Figure 10. Scheme summarising the proposed sequence of events leading to augmentation or 
exocytotic release of catecholamine from bovine chromaffin cells (BCCs). IG20 inserts 
into the plasma membrane through its lipophilic moiety (1) but can not enter the cytosol 
because of its hydrophilic sulphate sugar moiety (2); this causes an initial cell 
depolarization and the subsequent recruitment of Na+ channels at more hyperpolarizing 
potentials (3) to elicit TTX-sensitive superimposed action potentials (4) that will cause 
the opening of VACCs of the L-subtype (5), augmented Ca2+ entry and the elevation of 
[Ca2+]c (6); this will finally lead to the exocytotic release of catecholamine (7) as well as 
to the activation of BK channels (8) that may be responsible of the afterhyperpolarization 
of action potentials (4).  
  
